Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus Oxaliplatin vs S-1 alone in locally advanced gastric cancer
NCT02867839Phase 3Terminated
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Apr 2017
- Primary completion
- Sep 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in gastric cancer (GC), sponsored by Peking University Cancer Hospital & Institute. Started Apr 2017; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02867839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867839.